Effect of a peanut-rich weight loss diet on risk of diabetes

Comparison of a peanut-rich weight loss diet compared to a conventional weight loss diet over 6 months on serum insulin, plasma glucose and 2 hour glucose after a GTT in overweight adults at increased risk of diabetes

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12622001008718

Enrollment

107

Registered

2022-07-19

Start date

2021-02-01

Completion date

2021-05-31

Last updated

2022-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We aimed to show that a peanut-enriched weight loss diet would improve markers of diabetes compared with a standard low far weight loss diet. We expected given the same degree of energy restriction that both diets would provide a similar weight loss outcome

Interventions

weight loss diet containing 35g of peanuts before 2 main meals over 6 months in men and women with a BMI>26 at increased risk over type 2 diabetes. Both the peanut diet and the control diet were calorie controlled (1500-1600 calories) but composition was not specified. Peanuts were provided to the peanut group and equivalent value vouchers to the control group. The Duration of the diet was 6 months. Food records were filled in as well as a daily peanut consumption record

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Prevention

Masking

Blinded (masking used) (Investigator)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

BMI>26 AUSDRISK score>6

Exclusion criteria

Exclusion criteria were previous surgery for weight reduction, systolic blood pressure >160mmHg, currently undergoing medical treatment for acute illness, participation in an-other ongoing clinical trial, current weight loss diet and unwillingness to eat peanuts. In-dividuals taking diabetes or obesity medication were not eligible.

Outcome results